Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.5588
-0.0154 (-2.68%)
At close: May 23, 2025, 4:00 PM
0.5600
+0.0012 (0.21%)
After-hours: May 23, 2025, 7:56 PM EDT

Century Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Revenue
114.96.592.245.2--
Upgrade
Revenue Growth (YoY)
8286.72%194.81%-57.01%---
Upgrade
Cost of Revenue
110.4107.2492.7197.1775.65-
Upgrade
Gross Profit
4.5-100.66-90.48-91.97-75.65-
Upgrade
Selling, General & Admin
34.1834.5134.7131.8619.249.5
Upgrade
Research & Development
-----39.68
Upgrade
Operating Expenses
34.1834.5134.7131.8619.2449.18
Upgrade
Operating Income
-29.68-135.17-125.18-123.83-94.88-49.18
Upgrade
Interest Expense
---0.54-1.43-1.28-0.38
Upgrade
Interest & Investment Income
12.1913.0112.684.420.380.7
Upgrade
Other Non Operating Income (Expenses)
0.310.35-0.38---
Upgrade
EBT Excluding Unusual Items
-17.18-121.81-113.43-120.84-95.78-48.85
Upgrade
Impairment of Goodwill
-4.33-4.33----
Upgrade
Asset Writedown
---16.37---
Upgrade
Other Unusual Items
1.361.36----
Upgrade
Pretax Income
-20.16-124.78-134.79-130.84-95.78-53.58
Upgrade
Income Tax Expense
1.791.791.880.090.04-
Upgrade
Net Income
-21.94-126.57-136.67-130.93-95.82-53.58
Upgrade
Net Income to Common
-21.94-126.57-136.67-130.93-95.82-53.58
Upgrade
Shares Outstanding (Basic)
85795958327
Upgrade
Shares Outstanding (Diluted)
85795958327
Upgrade
Shares Change (YoY)
40.41%32.60%2.70%78.30%332.95%10.43%
Upgrade
EPS (Basic)
-0.26-1.61-2.30-2.27-2.96-7.16
Upgrade
EPS (Diluted)
-0.26-1.61-2.30-2.27-2.96-7.16
Upgrade
Free Cash Flow
-114.6-110.29-102.08-16.55-133.97-51.09
Upgrade
Free Cash Flow Per Share
-1.35-1.40-1.72-0.29-4.14-6.83
Upgrade
Operating Margin
-25.83%-2051.39%-5600.94%-2381.82%--
Upgrade
Profit Margin
-19.10%-1920.87%-6115.12%-2518.41%--
Upgrade
Free Cash Flow Margin
-99.74%-1673.84%-4567.52%-318.37%--
Upgrade
EBITDA
-16.38-121.86-112.14-115.39-91.14-47.77
Upgrade
D&A For EBITDA
13.313.313.048.443.751.4
Upgrade
EBIT
-29.68-135.17-125.18-123.83-94.88-49.18
Upgrade
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q